Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Markova, Oksana"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Information Technologies and Learning Tools 46 (2015) 29-44
The research goal is to investigate the evolution of the concept of utility computing in the works of foreign researchers in the years 1959-1966. First the A. O. Mann's results and expanded overview of the D. F. Parkhill's results on the concept of c
Externí odkaz:
http://arxiv.org/abs/1807.07849
Publikováno v:
CEUR Workshop Proceedings 2104 (2018) 388-403
The role of neural network modeling in the learning content of the special course "Foundations of Mathematical Informatics" was discussed. The course was developed for the students of technical universities - future IT-specialists and directed to bre
Externí odkaz:
http://arxiv.org/abs/1807.00795
Autor:
Markova, Oksana, Garipova, Svetlana, Chistoedova, Aelita, Matyunina, Viktoriia, Lubyanova, Alsu, Lastochkina, Oksana, Garipov, Arsenii, Shpirnaya, Irina, Pusenkova, Lyudmila
Publikováno v:
Plants (2223-7747); Jul2024, Vol. 13 Issue 13, p1769, 20p
Autor:
Bokova, Tatyana N.1 bokovatn@mgpu.ru, Markova, Oksana V.2
Publikováno v:
ARPHA Proceedings. 2021, Issue 4, p141-153. 13p.
Autor:
Semerikov Serhiy, Teplytskyi Illia, Yechkalo Yuliia, Markova Oksana, Soloviev Vladimir, Kiv Arnold
Publikováno v:
SHS Web of Conferences, Vol 75, p 04018 (2020)
The article substantiates the necessity to develop training methods of computer simulation of neural networks in the spreadsheet environment. The systematic review of their application to simulating artificial neural networks is performed. The author
Externí odkaz:
https://doaj.org/article/01a164a677484f3a935e9a9ee5d9c57b
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab
Autor:
Kulagin, Alexander D., Ptushkin, Vadim V., Lukina, Elena A., Davydkin, Igor L., Korobkin, Alexander V., Shamrai, Vladimir S., Konstantinova, Tatyana S., Kaporskaya, Tatyana S., Mitina, Tatyana A., Ksenzova, Tatyana I., Zuev, Evgeny V., Markova, Oksana A., Gapchenko, Elena V., Kudlay, Dmitry A.
Publikováno v:
Annals of Hematology
Currently, eculizumab is the main effective treatment for paroxysmal nocturnal hemoglobinuria (PNH). The aim of this randomized multicenter noninferiority study was to evaluate the efficacy and safety of the Biosimilar (Elizaria) in comparison with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4e6bcc2cf84bb5e5f891556400dbf89
https://doi.org/10.1007/s00277-021-04624-7
https://doi.org/10.1007/s00277-021-04624-7